Role of excipients on solid-state properties of piroxicam during processing

Journal of Pharmaceutical Sciences

Volumn 101, Issue 3, 2012, Pages 1202-1211

  Christensen, Niels Peter Aae ^a   Cornett, Claus ^a   Rantanen, Jukka ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Chemometrics; Drying; Excipients; Granulation; Hydrate; Partial least squares; Phase transition; Physical stability; Raman spectroscopy; Solid state

Indexed keywords

ALCOHOL; BICARBONATE; EXCIPIENT; HYDROXYPROPYLCELLULOSE; MICROCRYSTALLINE CELLULOSE; PIROXICAM; SOLVENT;

ARTICLE; DEHYDRATION; RAMAN SPECTROMETRY; SCREENING; SOLID STATE; WATER ABSORPTION;

EID: 84855890587     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.23014     Document Type: Article

References (41)

1. Brittain HG, Grant DJ. 1999. Effects of polymorphism and solid-state solvation on solubility and dissolution rate. In Polymorphism in pharmaceutical solids; Brittain HG, Ed. 1sted. New York: Marcel Dekker Inc, pp 279-330.
2. Brittain HG, Fiese EF. 1999. Effects of pharmaceutical processing on drug polymorphs and solvates. In Polymorphism in pharmaceutical solids; Brittain HG, Ed. 1sted. New York: Marcel Dekker Inc, pp 331-362.
3. Vippagunta SR, Brittain HG, Grant DJ. 2001. Crystalline solids. Adv Drug Deliv Rev 48:3-26.
4. Zhang GG, Law D, Schmitt EA, Qiu Y. 2004. Phase transformation considerations during process development and manufacture of solid oral dosage forms. Adv Drug Deliv Rev 56:371-390.
5. Morris KR, Griesser UJ, Eckhardt CJ, Stowell JG. 2001. Theoretical approaches to physical transformations of active pharmaceutical ingredients during manufacturing processes. Adv Drug Deliv Rev 48:91-114.
6. Stephenson GA, Aburub A, Woods TA. 2011. Physical stability of salts of weak bases in the solid-state. J Pharm Sci 100:1607-1617.
7. Wikström H, Carroll WJ, Taylor LS. 2008. Manipulating theophylline monohydrate formation during high-shear wet granulation through improved understanding of the role of pharmaceutical excipients. Pharm Res 25:923-935.
8. Tian F, Saville DJ, Gordon KC, Strachan CJ, Zeitler JA, Sandler N, Rades T. 2007. The influence of various excipients on the conversion kinetics of carbamazepine polymorphs in aqueous suspension. J Pharm Pharmacol 59:193-201.
9. Wikström H, Rantanen J, Gift AD, Taylor LS. 2008. Toward an understanding of the factors influencing anhydrate-to-hydrate transformation kinetics in aqueous environments. Cryst Growth Des 8:2684-2693.
10. Jørgensen A, Rantanen J, Karjalainen M, Khriachtchev L, Räsänen E, Yliruusi J. 2002. Hydrate formation during wet granulation studied by spectroscopic methods and multivariate analysis. Pharm Res 19:1285-1291.
11. Wikström H, Marsac PJ, Taylor LS. 2005. In-line monitoring of hydrate formation during wet granulation using Raman spectroscopy. J Pharm Sci 94:209-219.
12. Amado AM, Nolasco MM, Ribeiro-Claro PJ. 2007. Probing pseudopolymorphic transitions in pharmaceutical solids using Raman spectroscopy: Hydration and dehydration of theophylline. J Pharm Sci 96:1366-1379.
13. Jørgensen AC, Strachan CJ, Pöllänen KH, Koradia V, Tian F, Rantanen J. 2009. An insight into water of crystallization during processing using vibrational spectroscopy. J Pharm Sci 98:3903-3932.
14. Kogermann K, Aaltonen J, Strachan CJ, Pöllänen K, Heinämäki J, Yliruusi J, Rantanen J. 2008. Establishing quantitative in-line analysis of multiple solid-state transformations during dehydration. J Pharm Sci 97:4983-4999.
15. Airaksinen S, Karjalainen M, Räsänen E, Rantanen J, Yliruusi J. 2004. Comparison of the effects of two drying methods on polymorphism of theophylline. Int J Pharm 276:129-141.
16. Karjalainen M, Airaksinen S, Rantanen J, Aaltonen J, Yliruusi J. 2005. Characterization of polymorphic solid-state changes using variable temperature X-ray powder diffraction. J Pharm Biomed Anal 39:27-32.
17. Galwey AK. 2000. Structure and order in thermal dehydrations of crystalline solids. Thermochim Acta 355:181-238.
18. Petit S, Coquerel G. 1996. Mechanism of several solid-solid transformations between dihydrated and anhydrous copper(II) 8-hydroxyquinolinates. Proposition for a unified model for the dehydration of molecular crystals. Chem Mater 8:2247-2258.
19. Salameh AK, Taylor LS. 2006. Physical stability of crystal hydrates and their anhydrates in the presence of excipients. J Pharm Sci 95:446-461.
20. Heinz A, Strachan CJ, Gordon KC, Rades T. 2009. Analysis of solid-state transformations of pharmaceutical compounds using vibrational spectroscopy. J Pharm Pharmacol 61:971-988.
21. Wold S, Sjöström M, Eriksson L. 2001. PLS-regression: A basic tool of chemometrics. Chemom Intell Lab Syst 58:109-130.
22. Roggo Y, Chalus P, Maurer L, Lema-Martinez C, Edmond A, Jent N. 2007. A review of near infrared spectroscopy and chemometrics in pharmaceutical technologies. J Pharm Biomed Anal 44:683-700.
23. Rinnan Å, van den Berg F, Engelsen SB. 2009. Review of the most common pre-processing techniques for near-infrared spectra. Trends Anal Chem 28:1201-1222.
24. Nørgaard L, Saudland A, Wagner J, Nielsen JP, Munck L, Engelsen SB. 2000. Interval partial least-squares regression (iPLS): A comparative chemometric study with an example from near-infrared spectroscopy. Appl Spectrosc 54:413-419.
25. Andersen CM, Bro R. 2010. Variable selection in regression-a tutorial. J Chemom 24:728-737.
26. 6, 2-benzothiazine-3-carboxamide 1, 1-dioxide (piroxicam). Acta Cryst B 38:2948-2951.
27. Allen FH. 2002. The Cambridge Structural Database: A quarter of a million crystal structures and rising. Acta Cryst B 58:380-388.
28. 2O. Acta Cryst C 40:989-990.
29. Ciurczak EW, Drennen JK III. 2002. Pharmaceutical assays. Pharmaceutical and medical applications of near-infrared spectroscopy. 1st ed. New York: Marcel Dekker Inc, pp 73-106.
30. Nørgaard L, Hahn MT, Knudsen LB, Farhat IA, Engelsen SB. 2005. Multivariate near-infrared and Raman spectroscopic quantifications of the crystallinity of lactose in whey permeate powder. Int Dairy J 15:1261-1270.
31. Bassompierre M, Munck L, Bro R, Engelsen SB. 2004. Rapid dioxin assessment in fish products by fatty acid pattern recognition. Analyst 129:553-558.
32. de Juan A, Tauler R. 2006. Multivariate curve resolution (MCR) from 2000: Progress in concepts and applications. Crit Rev Anal Chem 36:163-176.
33. Fransson M, Johansson J, Sparén A, Svensson O. 2010. Comparison of multivariate methods for quantitative determination with transmission Raman spectroscopy in pharmaceutical formulations. J Chemom 24:674-680.
34. Azzouz T, Tauler R. 2008. Application of multivariate curve resolution alternating least squares (MCR-ALS) to the quantitative analysis of pharmaceutical and agricultural samples. Talanta 74:1201-1210.
35. Lachenmeier DW, Kessler W. 2008. Multivariate curve resolution of spectrophotometric data for the determination of artificial food colors. J Agric Food Chem 56:5463-5468.
36. Zhu H, Yuen C, Grant DJW. 1996. Influence of water activity in organic solvent plus water mixtures on the nature of the crystallizing drug phase. 1. Theophylline Int J Pharm 135:151-160.
37. Qu H, Louhi-Kultanen M, Kallas J. 2006. Solubility and stability of anhydrate/hydrate in solvent mixtures. Int J Pharm 321:101-107.
38. Bernhard E, Zimmermann F. 1984. Contribution to the understanding of oxicam ionization constants. Arzneimittelforschung 34:647-648.
39. Zannou EA, Ji Q, Joshi YM, Serajuddin AT. 2007. Stabilization of the maleate salt of a basic drug by adjustment of microenvironmental pH in solid dosage form. Int J Pharm 337:210-218.
40. Taylor LS, York P. 1998. Effect of particle size and temperature on the dehydration kinetics of trehalose dihydrate. Int J Pharm 167:215-221.
41. Koradia V, de Diego HL, Elema MR, Rantanen J. 2010. Integrated approach to study the dehydration kinetics of nitrofurantoin monohydrate. J Pharm Sci 99:3966-3976.